Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure

Kidney International

Volumn 62, Issue 4, 2002, Pages 1372-1378

  Bennett Richards, Katy J ^a,b,c   Kattenhorn, Mia ^a,b,c   Donald, Ann E ^a,b,c   Oakley, Gillian R ^a,b,c   Varghese, Zac ^a,b,c   Bruckdorfer, K Richard ^a,b,c   Deanfield, John E ^a,b,c   Rees, Lesley ^a,b,c  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Atherosclerosis; Cardiovascular disease; Childhood ESRD; Dietary supplements; Nitric oxide synthesis; Renal failure; Uremic toxicity

Indexed keywords

ARGININE; GLYCERYL TRINITRATE;

ADOLESCENT; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BIOCHEMISTRY; BRACHIAL ARTERY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; ENDOTHELIUM LESION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; LIPID ANALYSIS; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SHEAR STRESS; ULTRASOUND; VASOMOTOR REFLEX;

EID: 0036378157     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00555.x     Document Type: Article

References (26)

1. LEVEY AS, BETO JA, CORONADO BE, et al: Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32:853-906, 1998
2. KARI JA, DONALD AE, VALLANCE DT, et al: Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 52:468-472, 1997
3. COOKE JP, TSAO PS: Is NO an endogenous antiatherogenic molecule? Arterioscler Thromb 14:653-655, 1994
4. MENDES RA, BRUNINI TM, ELLORY JC, MANN GE: Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure. Cardiovasc Res 49:697-712, 2001
5. MACALLISTER RJ, RAMBAUSEK MH, VALLANCE P, et al: Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. Nephrol Dial Transplant 11:2449-2452, 1996
6. MACALLISTER RJ, WHITLEY GS, VALLANCE P: Effects of guanidino and uremic compounds on nitric oxide pathways. Kidney Int 45:737-742, 1994
7. VAZIRI ND, OVEISI F, DING Y: Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int 53:1748-1754, 1998
8. CLARKSON P, ADAMS MR, POWE AJ, et al: Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest 97:1989-1994, 1996
9. JEREMY RW, MCCARRON H, SULLIVAN D: Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilatation in the hypercholesterolemic rabbit. Response according to treatment duration, anatomic site, and sex. Circulation 94:498-506, 1996
10. MCDOWELL IF, MCENENY J, TRIMBLE ER: A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein. Ann Clin Biochem 32(Pt 2):167-174, 1995
11. CHAPPLE IL, MASON GI, GARNER I, et al: Enhanced chemiluminescent assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid. Ann Clin Biochem 34(Pt 4):412-421, 1997
12. FOLEY RN, PARFREY PS, SARNAK MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 (Suppl):S112-S119, 1998
13. RUBANYI GM, ROMERO JC, VANHOUTTE PM: Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 250:H1145-H1149, 1986
14. SORENSEN KE, CELERMAJER DS, SPIEGELHALTER DJ, et al: Non-invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility. Br Heart J 74:247-253, 1995
15. SCHMIDT RJ, BAYLIS C: Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 58:1261-1266, 2000
16. DREXLER H, ZEIHER AM, MEINZER K, JUST H: Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 338:1546-1550, 1991
17. CEREMUZYNSKI L, CHAMIEC T, HERBACZYNSKA-CEDRO K: Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol 80:331-333, 1997
18. TOUSOULIS D, DAVIES G, TENTOLOURIS C, et al: Coronary stenosis dilatation induced by L-arginine. Lancet 349:1812-1813, 1997
19. JAY MT, CHIRICO S, SIOW RC, et al: Modulation of vascular tone by low density lipoproteins: Effects on L-arginine transport and nitric oxide synthesis. Exp Physiol 82:349-360, 1997
20. G-monomethyl-L-arginine uptake: A mechanism for differential inhibition of NO synthases? Am J Physiol 269:C750-C756, 1995
21. VERGNANI L, HATRIK S, RICCI F, et al: Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production: Key role of L-arginine availability. Circulation 101: 1261-1266, 2000
22. DE NICOLA L, BELLIZZI V, MINUTOLO R, et al: Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure. Kidney Int 56:674-684, 1999
23. STROES E, KASTELEIN J, COSENTINO F, et al: Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 99:41-46, 1997
24. CELERMAJER DS, SORENSEN KE, GOOCH VM, et al: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111-1115, 1992
25. ANDERSON TJ, UEHATA A, GERHARD MD, et al: Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26:1235-1241, 1995
26. SORENSEN KE, KRISTENSEN IB, CELERMAJER DS: Atherosclerosis in the human brachial artery. J Am Coll Cardiol 29:318-322, 1997